Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - hisataka+kobayashi
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Combination of Near Infrared Photoimmunotherapy Targeting Cancer Cells and Host-Immune Activation
Abstract: Common methods of cancer therapy largely rely on either direct killing of cancer cells or activation of the host immune response to do so, but not both. A recently developed treatment of tumors uses an antibody/photo-absorber, Ab-IR700, with near infrared photoimmunotherapy (NIR-PIT), to selectively kill IR700-bound and NIR-light-exposed cancer...
Published: 9/19/2024
|
Inventor(s):
Hisataka Kobayashi
,
Peter Choyke
Keywords(s):
antibody-IR700
,
Combination Therapy
,
Immunomodulators
,
Immunotherapy
,
Kobayashi
,
Metastasis
,
Near-Infrared Photo Immunotherapy
,
NIR-PIT
,
Photochemical
,
Tumor Inhibition
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Therapeutics
,
TherapeuticArea > Oncology
Near-IR Light-Cleavable Antibody Conjugates and Conjugate Precursors
Abstract: This invention describes a general way to trigger the release of a bioactive small molecule from a targeting antibody. The key “trigger” is a fluorescent linker that is chemically disassembled upon irradiation with light in the near-IR range (~800 nm). This linker technology is a dramatic step forward for the field. The molecules can be tracked...
Published: 4/8/2024
|
Inventor(s):
Martin Schnermann
,
Alexander Gorka
,
Hisataka Kobayashi
,
Roger Nani
Keywords(s):
ADC
,
Antibody-drug Conjugate
,
Chemical linkers
,
Fluorescent linker
,
PDT
,
personalized medicine
,
Photodynamic therapy
,
Targeted drug release
,
Targeted therapy
Category(s):
TherapeuticArea > Oncology
,
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
Application > Therapeutics
Removal of Selected Proteins Using Light Energy: Photoimmunotherapy
Abstract: Researchers at the NCI Laboratory of Molecular Theranostics and the Molecular Imaging Program have developed a new method to modify, isolate and remove a single chemically-labeled molecule or a cluster of proteins associated with the chemically-labeled protein. The chemical label can be an antigen-antibody complex. This discovery is based...
Published: 4/8/2024
|
Inventor(s):
Hisataka Kobayashi
,
Martin Schnermann
,
Peter Choyke
Keywords(s):
AGGREGATION
,
Fluorophore
,
IR700
,
photoactivation
,
Photoimmunotherapy
Category(s):
Collaboration Sought > Licensing
,
Application > Research Materials
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Oncology